References
- Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization Classification of Tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131:803–820.
- Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10(5):459–466. .
- Ammer L-M, Vollmann-Zwerenz A, Ruf V, et al. The role of translocator protein TSPO in hallmarks of glioblastoma. Cancers (Basel). 2020;12(10):1–10.
- Byron SA, Tran NL, Halperin RF, et al. Prospective feasibility trial for genomics-informed treatment in recurrent and progressive glioblastoma. Clin Cancer Res. 2018;24(2):295–305. .
- Navarria P, Ascolese AM, Tomatis S, et al. Hypofractionated stereotactic radiation therapy in recurrent high-grade glioma: a new challenge. Cancer Res Treat. 2016;48:37–44.
- Zhou L, Tang H, Wang F, et al. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma. Mol Med Rep. 2018;18(5):4185–4196.
- Chen CM, Huang HZ, Wu CH. Protein bioinformatics databases and resources. Methods Mol Biol. 2011;694:3–24.
- Listik E, Horst B, Choi AS, et al. A bioinformatic analysis of the inhibin-betaglycan-endoglin/CD105 network reveals prognostic value in multiple solid tumors. PLOS ONE. 2021;16(4):e0249558.
- Zhang B, Horvath S. A general framework for weighted gene co-expression network analysis. Statistical Applications in Genetics and Molecular Biology. 2005;4(1). Article17. DOI:10.2202/1544-6115.1128.
- Pei G, Chen L, Zhang W. WGCNA application to proteomic and metabolomic data analysis. Methods Enzymol. 2017;585:135–158.
- Wan Q, Tang J, Han Y, et al. Co-expression modules construction by WGCNA and identify potential prognostic markers of uveal melanoma. Exp Eye Res. 2018;166:13–20.
- Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.
- Zhao W, Langfelder P, Fuller T, et al. Weighted gene coexpression network analysis: state of the art. Journal of Biopharmaceutical Statistics. 2010;20(2):281–300.
- Kakati T, Bhattacharyya DK, Barah P, et al. Comparison of methods for differential co-expression analysis for disease biomarker prediction. Comput Biol Med. 2019;113:103380.
- Zhang DL, Zhao JX, Han CZ, et al. Identification of hub genes related to prognosis in glioma. Biosci Rep.
- Chen T-Y, Liu Y, Chen L, et al. Identification of the potential biomarkers in patients with glioma: a weighted gene co-expression network analysis. Carcinogenesis. 2020;41(6):743–750.
- Toyama R, Curtiss PE, Otani H, et al. LIM class homeobox gene lim5: implied role in CNS patterning in Xenopus and zebrafish. Dev Biol. 1995;170:583–593.
- Heide M, Zhang Y, Zhou X, et al. Lhx5 controls mamillary differentiation in the developing hypothalamus of the mouse. Frontiers in Neuroanatomy. 2015;9:113.
- Paylor R, Zhao Y, Libbey M, et al. Learning impairments and motor dysfunctions in adult Lhx5-deficient mice displaying hippocampal disorganization. Physiol Behav. 2001;73(5):781–792.
- Wang X, He C, Hu X. LIM homeobox transcription factors, a novel subfamily which plays an important role in cancer (review). Oncol Rep. 2014;31(5):1975–1985.
- Dear TN, Sanchez-Garcia I, Rabbitts TH. The HOX11 gene encodes a DNA-binding nuclear transcription factor belonging to a distinct family of homeobox genes. Proc Natl Acad Sci U S A. 1993;90(10):4431–4435.
- Riz I, Lee HJ, Baxter KK, et al. Transcriptional activation by TLX1/HOX11 involves Gro/TLE corepressors. Biochem Biophys Res Commun. 2009;380(2):361–365.
- Lenti E, Farinello D, Yokoyama KK, et al. Transcription factor TLX1 controls retinoic acid signaling to ensure spleen development. J Clin Invest. 2016;126(7):2452–2464. .
- Kim EL, Sorokin M, Kantelhardt SR, et al. Intratumoral heterogeneity and longitudinal changes in gene expression predict differential drug sensitivity in newly diagnosed and recurrent glioblastoma. Cancers (Basel). 2020;12(2):520. .
- Diboun I, Wernisch L, Orengo CA, et al. Microarray analysis after RNA amplification can detect pronounced differences in gene expression using limma. BMC Genomics. 2006;7(1):252.
- Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–15550. .
- Wang W, Zhao Z, Wu F, et al. Bioinformatic analysis of gene expression and methylation regulation in glioblastoma. J Neurooncol. 2018;136(3):495–503.
- Tomczak K, Czerwińska P, Wiznerowicz M. The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemporary Oncology (Poznan, Poland). 2015;19(1A):A68–77.
- Kawaguchi A, Yajima N, Tsuchiya N, et al. Gene expression signature-based prognostic risk score in patients with glioblastoma. Cancer Science. 2013;104(9):1205–1210.
- Zhao C. Identifying the hub gene and immune infiltration of osteoarthritis by bioinformatical methods. Clin Rheumatol. 2021;40(3):1027–1037.
- Najafi M, Farhood B, Mortezaee K. Contribution of regulatory T cells to cancer: a review. J Cell Physiol. 2019;234(6):7983–7993.
- Hobert O, Westphal H. Functions of LIM-homeobox genes. Trends Genet. 2000;16(2):75–83.
- Akhir MKAM, Choy CS, Abdullah MA, et al. The Role of ISL1 and LHX5 LIM Homeobox Genes in Bladder Tumourigenesis. Malays J Med Sci. 2020;27(1):37–45.
- Zhao Y, Hermesz E, Yarolin MC, et al. Genomic structure, chromosomal localization and expression of the human LIM–homeobox gene LHX5. Gene. 2000;260(1–2):95–101.
- De Keersmaecker KK, Ferrando AA. TLX1-Induced T-cell Acute Lymphoblastic Leukemia: figure 1. Clin Cancer Res. 2011;17(20):6381–6386.
- Heidari M, Rice KL, Phillips JK, et al. The nuclear oncoprotein TLX1/HOX11 associates with pericentromeric satellite 2 DNA in leukemic T-cells. Leukemia. 2006;20(2):304–312.
- Durinck K, Van Loocke W, Van der Meulen J, et al. Characterization of the genome-wide TLX1 binding profile in T-cell acute lymphoblastic leukemia. Leukemia. 2015;29(12):2317–2327. .
- Andreiuolo F, Puget S, Peyre M, et al. Neuronal differentiation distinguishes supratentorial and infratentorial childhood ependymomas. Neuro Oncol. 2010;12(11):1126–1134.
- Vengoji R, Macha MA, Nimmakayala RK, et al. Afatinib and temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells. J Exp Clin Cancer Res. 2019;38(1):266. .
- Zieker D, Bühler S, Ustündag Z, et al. Induction of tumor stem cell differentiation—novel strategy to overcome therapy resistance in gastric cancer. Langenbecks Arch Surg. 2013;398(4):603–608. .
- Clark PA, Iida M, Treisman DM, et al. Activation of multiple ERBB family receptors mediates glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibition. Neoplasia. 2012;14:420–428.